DV
Dividend Vision

NPCE — Neuropace Inc

Neuropace Inc (NPCE)

Total return is -40.8% over the past 5.3 years, 142.9 points behind SPY at 102.1%. Its deepest 1-year drawdown was 33.2%.

NPCE is an equity fund focused on NeuroPage Inc, a medical device company specializing in neurostimulation therapies. As a single-stock fund, it does not generate dividend distributions and carries no stated expense ratio or distribution rate. This fund structure appeals primarily to investors seeking direct exposure to the company's equity performance rather than income generation.

NPCE key facts

Asset type
Stock
Asset class
Equity
Inception date
04/22/2021
Last close
$14.77
Market cap
$527,089,280
Average volume
155000.0
Beta
1.889
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.64